Gavi Approves Core Funding For Inactivated Poliovirus Vaccine Until 2020 To Continue Work To End Polio

Global Polio Eradication Initiative: Gavi Board Funds Inactivated Poliovirus Vaccine Until 2020
“In the fight against the virus, two important tools are used to help prevent polio — two safe, effective vaccines. Only through full funding of these vaccines can worldwide immunity be achieved, and the virus eradicated. Redoubling commitment towards this goal, last week, Gavi, The Vaccine Alliance approved core funding for the inactivated poliovirus vaccine (IPV) for 2019 and 2020 to continue work to end polio and protect every child…” (6/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.